Ana Cristina Bairrada Fortuna


AuthID: R-000-NY0

Confirmed Publications: 125



61
TITLE: Nose-to-brain delivery of levetiracetam after intranasal administration to mice  Full Text
AUTHORS: Gonçalves, J; Bicker, J; Gouveia, F; Liberal, J; Oliveira, RC; Alves, G; Falcão, A ; Fortuna, A ;
PUBLISHED: 2019, SOURCE: International journal of pharmaceutics, VOLUME: 564
INDEXED IN: Scopus CrossRef: 43
IN MY: ORCID | CIÊNCIAVITAE
62
TITLE: Novel bioanalytical method for the quantification of rufinamide in mouse plasma and tissues using HPLC-UV: A tool to support pharmacokinetic studies  Full Text
AUTHORS: Meirinho, S; Rodrigues, M; Fortuna, A ; Falcao, A ; Alves, G;
PUBLISHED: 2019, SOURCE: JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, VOLUME: 1124
INDEXED IN: Scopus WOS CrossRef: 9
IN MY: ORCID | CIÊNCIAVITAE
63
TITLE: Rethinking carbamazepine oral delivery using polymer-lipid hybrid nanoparticles  Full Text
AUTHORS: Ana, R; Mendes, M; Sousa, J; Pais, A; Falcao, A ; Fortuna, A ; Vitorino, C;
PUBLISHED: 2019, SOURCE: INTERNATIONAL JOURNAL OF PHARMACEUTICS, VOLUME: 554
INDEXED IN: Scopus WOS CrossRef: 47
IN MY: ORCID | CIÊNCIAVITAE
64
TITLE: Silymarin as a flavonoid-type P-glycoprotein inhibitor with impact on the pharmacokinetics of carbamazepine, oxcarbazepine and phenytoin in rats  Full Text
AUTHORS: Ferreira, A; Rodrigues, M; Meirinho, S; Fortuna, A ; Falcao, A ; Alves, G;
PUBLISHED: 2019, SOURCE: DRUG AND CHEMICAL TOXICOLOGY, VOLUME: 44, ISSUE: 5
INDEXED IN: Scopus WOS CrossRef: 13
IN MY: ORCID | CIÊNCIAVITAE
65
TITLE: Sugar-Lowering Drugs for Type 2 Diabetes Mellitus and Metabolic Syndrome-Review of Classical and New Compounds: Part-I
AUTHORS: Vieira, R; Souto, SB; Sanchez Lopez, E; Machado, AL; Severino, P; Jose, S; Santini, A; Fortuna, A ; Garcia, ML; Silva, AM ; Souto, EB ;
PUBLISHED: 2019, SOURCE: PHARMACEUTICALS, VOLUME: 12, ISSUE: 4
INDEXED IN: Scopus WOS CrossRef: 52 Handle
IN MY: ORCID | CIÊNCIAVITAE
66
TITLE: Sugar-Lowering Drugs for Type 2 Diabetes Mellitus and Metabolic Syndrome-Strategies for In Vivo Administration: Part-II
AUTHORS: Vieira, R; Souto, SB; Sanchez Lopez, E; Machado, AL; Severino, P; Jose, S; Santini, A; Silva, AM ; Fortuna, A ; Garcia, ML; Souto, EB ;
PUBLISHED: 2019, SOURCE: JOURNAL OF CLINICAL MEDICINE, VOLUME: 8, ISSUE: 9
INDEXED IN: Scopus WOS CrossRef: 36 Handle
IN MY: CIÊNCIAVITAE
67
TITLE: 2 In vitro assessment of the interactions of dopamine beta-hydroxylase inhibitors with human P-glycoprotein and Breast Cancer Resistance Protein  Full Text
AUTHORS: Bicker, J; Alves, G; Fortuna, A ; Soares da Silva, P; Falcao, A ;
PUBLISHED: 2018, SOURCE: EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, VOLUME: 117
INDEXED IN: Scopus WOS CrossRef: 10
IN MY: ORCID | CIÊNCIAVITAE
68
69
TITLE: Development and validation of an HPLC-FLD technique for colistin quantification and its plasma monitoring in hospitalized patients  Full Text
AUTHORS: Pinho, AR; Rocha, MJ; Alves, G; Falcao, AC ; Fortuna, AC ;
PUBLISHED: 2018, SOURCE: ANALYTICAL METHODS, VOLUME: 10, ISSUE: 3
INDEXED IN: Scopus WOS CrossRef: 6
IN MY: ORCID | CIÊNCIAVITAE
70
Page 7 of 13. Total results: 125.

footer slogan

Useful Links

Get Help

© 2025 CRACS & Inesc TEC - All Rights Reserved Privacy Policy | Terms of Service